Levodopa-induced psychosis can complicate the treatment of Parkinson's disease (PD). In
this retrospective, uncontrolled report, we describe our experience treating PD-related …

We treated 17 patients with Parkinson's disease (PD) complicated by psychosis with the
atypical antipsychotic drug, clozapine, for 6 to 24 months (mean, 15 months) in a …

The objective of this study was to monitor the long-term effect of clozapine administered to
Parkinson's disease (PD) patients with psychosis. Confusion, visual hallucinations, and …

Background Clozapine has gained acceptance as an antipsychotic in treatment-resistant
schizophrenia. Its low propensity to induce extrapyramidal side effects makes clozapine an …

Objective: To compare the efficacy and safety of clozapine in drug induced psychosis in
Parkinson's disease (PD). Methods: A four week, randomised, double blind, parallel …

Article abstract-Delusions and other manifestations of psychotic behavior are common side
effects in Parkinson's disease (PD) patients chronically treated with dopaminergic drugs …

Dopaminergic psychosis frequently complicates the pharmacological treatment of
Parkinson's disease. Dose reduction of dopaminomimetic therapy of treatment with …

Background Drug-induced psychosis is a difficult problem to manage in patients with
Parkinson's disease. Multiple open-label studies have reported that treatment with clozapine …

Treating psychosis in patients with Parkinson's disease (PD) is one of the more difficult
problems in clinical psychiatry. In this case report, a patient with PD and psychosis was …

Psychosis secondary to dopaminergic therapy can limit the ability to manage motor
symptoms of advanced Parkinson's disease (PD). We report the results of an open label 3 …